{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T12:41:03Z","timestamp":1765888863637},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T00:00:00Z","timestamp":1649635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T00:00:00Z","timestamp":1649635200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"TDR","award":["B40323","B40323","B40323"],"award-info":[{"award-number":["B40323","B40323","B40323"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Introduction<\/jats:title>\n                <jats:p>Throughout the world tuberculosis (TB) is the second leading cause of death due to an infectious agent. The World Health Organization promotes Isoniazid Preventive Therapy (IPT) in children under 5\u00a0years who are contacts of persons diagnosed with smear-positive pulmonary TB (SPPTB). In 2019, 33% of children identified as contacts received IPT globally, while in the Americas 11 countries reached coverages\u2009\u2265\u200975%, only 35% did so in the Dominican Republic (DR). The aim of this study was to identify barriers and facilitators for IPT administration in children under 5 in the Area IV Directorate of Health of the DR\u2019s National District.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Descriptive study, using mixed methods and sequential explanatory approach. We characterized children under 5\u00a0years who were contacts of a person with SPPTB. Later, semi-structured interviews and content analysis allowed identification of barriers and facilitators for IPT administration in children who were contacts of a person diagnosed with SPPTB, as perceived by relatives and health system personnel.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 238 children were identified as contacts of 174 persons with SPPTB: 36% of these received IPT while no data on IPT administration was found for 11% of them. The proportion of children who had a tuberculin skin test (TST) done was\u2009&lt;\u200920%. However, those who had the test done had a greater opportunity to receive IPT (OR: 8.12, CI 95%: 1.60\u201341.35). Barriers identified include socioeconomic conditions of children and families, stigma, lack of information in clinical and follow-up records, lack of coordination between public and private providers and lack of coherence within national regulations. Facilitators include home based care of persons with TB and their contacts, transfer of treatment to a health centre near household, isoniazid availability, provision of information by health-workers and economic support for food and transportation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Incomplete data, lack of use of TST to rule out active TB, socioeconomic and cultural conditions, were barriers for IPT administration. Implementation of a person centred approach to care was found to be the main facilitator for IPT uptake. Administration of IPT depends predominantly on modifiable health system factors. This allows rapid identification of strategies to improve IPT administration.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-022-07333-2","type":"journal-article","created":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T10:04:06Z","timestamp":1649671446000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Barriers and facilitators for isoniazid preventive therapy (IPT) administration in children under 5\u00a0years of age in the Dominican Republic"],"prefix":"10.1186","volume":"22","author":[{"given":"Grey Idalia","family":"Benoit V\u00e1squez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Lucia","family":"Morrobel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dione","family":"Benjumea-Bedoya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helena","family":"del Corral-Londo\u00f1o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,4,11]]},"reference":[{"key":"7333_CR1","unstructured":"Organizaci\u00f3n Mundial de la Salud. Global Tuberculosis Report 2017. Ginebra, Suiza; 2017."},{"key":"7333_CR2","unstructured":"World Health Organization (WHO). WHO report on TB 2020 [Internet]. Vol. 1, Who. 2020. p. 232. Available from: https:\/\/www.who.int\/publications-detail-redirect\/9789240013131."},{"key":"7333_CR3","doi-asserted-by":"crossref","unstructured":"Annemieke B, Volz A. Tuberculosis infantil en las Am\u00e9ricas: desaf\u00edos, oportunidades y pasos a seguir. Resid\u00eancia Pedi\u00e1trica [Internet]. 2016 [cited 2016 Sep 20];6(1):11\u20135. Available from: http:\/\/residenciapediatrica.com.br\/detalhes\/186\/childhood-tb-in-the-americas--challenges--opportunities-and-steps-to-be-taken.","DOI":"10.25060\/residpediatr-2016.v6n1-02"},{"key":"7333_CR4","unstructured":"Ministerio de Salud P\u00fablica. Plan Estrat\u00e9gico de la respuesta nacional a la Tuberculosis, Rep\u00fablica Dominicana, 2015\u20132020. Santo Domingo, Rep\u00fablica Dominicana: Ministerio de Salud P\u00fablica; 2015. p. 6\u2013132."},{"key":"7333_CR5","unstructured":"Direcci\u00f3n General de Epidemiologia. Tendencia de eventos de notificacion obliatoria del 2004 al 2014 [Internet]. Distrito Nacional: Ministerio de Salud P\u00fablica; 2015 [cited 2016 Sep 20]. 75 p. Available from: http:\/\/digepisalud.gob.do\/documentos\/?drawer=AnalisisdeSituaci\u00f3n*An\u00e1lisisdeSituaci\u00f3ndeSalud."},{"key":"7333_CR6","unstructured":"Moctezuma M. La tuberculosis y sus determinantes sociales en las Am\u00e9ricas. El caso de M\u00e9xico. Secretaria de Salud. Centro Nacional de Programas Preventivos y Control de Enfermedades. Mexico, D.F.: Secretaria de Salud.; 2014."},{"key":"7333_CR7","unstructured":"Organizaci\u00f3n Mundial de la Salud. Estrategia mundial y metas para la prevenci\u00f3n, la atenci\u00f3n y el control de la tuberculosis despu\u00e9s de 2015. Ginebra, Suiza; 2013."},{"key":"7333_CR8","first-page":"125","volume-title":"Guidance for national tuberculosis programmes on the management of tuberculosis in children","author":"Organizaci\u00f3n Mundial de la Salud","year":"2014","unstructured":"Organizaci\u00f3n Mundial de la Salud. Guidance for national tuberculosis programmes on the management of tuberculosis in children. Suiza: WHO Library Cataloguing-in-Publication Data Guidance. Ginebra; 2014. p. 125."},{"key":"7333_CR9","unstructured":"Centros para el Control y Prevenci\u00f3n de Enfermedades. Guidelines for the investigation of contacts of persons with infectious tuberculosis. Recommendations from the National Tuberculosis Controllers Association and CDC. MMWR. 2005;54(RR-15):1\u201347."},{"key":"7333_CR10","unstructured":"Organizaci\u00f3n Mundial de la Salud. Recommendations for investigating contacts of persons with infectious tuberculosis in low- and middle-income countries. World Health Organization Ginebra, Suiza; 2012 p. 28\u201341."},{"key":"7333_CR11","unstructured":"Organizaci\u00f3n Mundial de la Salud. WHO | Guidelines on the management of latent tuberculosis infection. 2015 [cited 2016 Oct 17];38. Available from: http:\/\/www.who.int\/tb\/publications\/ltbi_document_page\/en\/."},{"key":"7333_CR12","unstructured":"Childhood Subgroup Stop TB Partnership WHO. Chapter 4: Childhood contact screening and management [Official Statement. Guidance for National Tuberculosis Programmes on the management of tuberculosis in children. Chapter 4 in the series]. Int J Tuberc Lung Dis. 2007; 11(4):12\u201315. Available from: http:\/\/www.ingentaconnect.com\/content\/iuatld\/ijtld\/2007\/00000011\/00000001\/art00003."},{"key":"7333_CR13","unstructured":"Organizaci\u00f3n Mundial de la Salud. Plan de acci\u00f3n para la prevenci\u00f3n y el control de la Tuberculosis. CD54\/11, Rev. 2015:26."},{"key":"7333_CR14","unstructured":"TB CARE I. International standards for tuberculosis care [Internet]. 3ra ed. The Hague. TB CARE I; 2014: 92. Available from: http:\/\/www.tbcare1.org\/publications."},{"key":"7333_CR15","unstructured":"World Health Organization (WHO). WHO report on TB 2020 [Internet]. Geneva; Available from: https:\/\/www.who.int\/publications-detail-redirect\/9789240013131."},{"key":"7333_CR16","unstructured":"Ministerio de Salud P\u00fablica. Gu\u00eda nacional para el diagn\u00f3stico, tratamiento y prevenci\u00f3n de tuberculosis en ni\u00f1os, ni\u00f1as y adolescentes. Resoluci\u00f3n Ministerial no. 00044 Rep\u00fablica Dominicana; 2012. p. 52."},{"key":"7333_CR17","unstructured":"Pe\u00f1a F. Eficiencia del estudio de contactos de pacientes con tuberculosis en territorios priorizados. Santo Domingo: Ministerio de Salud P\u00fablica; 2014. p. 50."},{"key":"7333_CR18","unstructured":"World Health Organization on behalf of the Special Programme for Research in Tropical Diseases Training. Implementation Research Toolkit [Internet]. Geneva: WHO; 2014. 188 p. Available from: http:\/\/adphealth.org\/irtoolkit\/."},{"key":"7333_CR19","first-page":"443","volume-title":"Designing and conducting mixed methods research","author":"J Creswell","year":"2011","unstructured":"Creswell J, Plano Clark V. Designing and conducting mixed methods research. Washington, DC: Sage Publications; 2011. p. 443."},{"key":"7333_CR20","unstructured":"Departamento de An\u00e1lisis de Situaci\u00f3n de Salud. Indicadores Basicos de Salud Rep\u00fablica Dominicana [Internet]. Distrito Nacional: Ministerio de Salud P\u00fablica; 2017 [cited 2017 May 5]. p. 30. Available from: http:\/\/www.msp.gob.do."},{"issue":"1","key":"7333_CR21","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13012-017-0561-4","volume":"12","author":"I Ayakaka","year":"2017","unstructured":"Ayakaka I, Ackerman S, Ggita JM, Kajubi P, Dowdy D, Haberer JE, et al. Identifying barriers to and facilitators of tuberculosis contact investigation in Kampala, Uganda: a behavioral approach. Implement Sci. 2017;12(1):33. https:\/\/doi.org\/10.1186\/s13012-017-0561-4.","journal-title":"Implement Sci"},{"key":"7333_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.11604\/pamj.2014.17.26.2641","volume":"17","author":"M Mindachew","year":"2014","unstructured":"Mindachew M, Deribew A, Memiah P, Biadgilign S. Perceived barriers to the implementation of isoniazid preventive therapy for people living with HIV in resource constrained settings: a qualitative study. Pan Afr Med J. 2014;17:1\u20136.","journal-title":"Pan Afr Med J"},{"key":"7333_CR23","unstructured":"D\u00edaza SP, Pita Fern\u00e1ndez S. Metodolog\u00eda de la Investigaci\u00f3n Asociaci\u00f3n de variables cualitativas: El test exacto de Fisher y el test de Mcnemar Autores. [cited 2021 Aug 30]; Available from: www.fisterra.com."},{"key":"7333_CR24","unstructured":"Ulin PR, Robinson ET, Tolley EE. Investigaci\u00f3n aplicada en salud p\u00fablica, M\u00e9todos cualitativos. Vol. 6, Organizaci\u00f3n Panamericana de la Salud. 2006. p. 1\u2013304."},{"key":"7333_CR25","first-page":"190","volume-title":"Paid\u00f3s","author":"K Krippendorff","year":"1990","unstructured":"Krippendorff K, Wolfson L. Metodolog\u00eda de an\u00e1lisis de contenido: teor\u00eda y pr\u00e1ctica. In: Ib\u00e9rica P, editor. Paid\u00f3s. Barcelona: Sage Publications; 1990. p. 190."},{"issue":"3","key":"7333_CR26","doi-asserted-by":"publisher","first-page":"199","DOI":"10.5588\/pha.13.0034","volume":"3","author":"M Osman","year":"2013","unstructured":"Osman M, Hesseling AC, Beyers N, Enarson DA, Rusen ID, Lombard C, et al. Routine programmatic delivery of isoniazid preventive therapy to children in Cape Town, South Africa. Public Health Action. 2013;3(3):199\u2013203.","journal-title":"Public Health Action."},{"issue":"2","key":"7333_CR27","doi-asserted-by":"publisher","first-page":"137","DOI":"10.17533\/udea.iatreia.v28n2a04","volume":"28","author":"D Benjumea Bedoya","year":"2015","unstructured":"Benjumea Bedoya D, Arbel\u00e1ez Montoya MP. Estudio y manejo cl\u00ednico de menores que conviven con pacientes de tuberculosis pulmonar, Medell\u00edn 2010\u20132011. IATREIA. 2015;28(2):137\u201347.","journal-title":"IATREIA."},{"issue":"8","key":"7333_CR28","doi-asserted-by":"publisher","first-page":"919","DOI":"10.5588\/ijtld.14.0072","volume":"18","author":"HR Shivaramakrishna","year":"2014","unstructured":"Shivaramakrishna HR, Frederick A, Shazia A, Murali L, Satyanarayana S, Nair SA, et al. Isoniazid preventive treatment in children in two districts of South India: does practice follow policy? Int J Tuberc Lung Dis. 2014;18(8):919\u201324.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"1","key":"7333_CR29","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1756-0500-5-7","volume":"5","author":"ME Rutherford","year":"2012","unstructured":"Rutherford ME, Ruslami R, Maharani W, Yulita I, Lovell S, Van Crevel R, et al. Adherence to isoniazid preventive therapy in Indonesian children: a quantitative and qualitative investigation. BMC Res Notes. 2012;5(1):7.","journal-title":"BMC Res Notes"},{"issue":"1","key":"7333_CR30","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1186\/s13104-015-1451-y","volume":"8","author":"A Makoni","year":"2015","unstructured":"Makoni A, Chemhuru M, Tshimanga M, Gombe NT, Mungati M, Bangure D. Evaluation of the isoniazid preventive therapy (IPT) program in Shurugwi District, Midlands Province, Zimbabwe, January 2013 to August 2014. BMC Res Notes. 2015;8(1):476.","journal-title":"BMC Res Notes"},{"issue":"5","key":"7333_CR31","doi-asserted-by":"publisher","first-page":"e0155525","DOI":"10.1371\/journal.pone.0155525","volume":"11","author":"Y Tadesse","year":"2016","unstructured":"Tadesse Y, Gebre N, Daba S, Gashu Z, Habte D, Hiruy N, et al. Uptake of isoniazid preventive therapy among under-five children: TB contact investigation as an entry point. PLoS ONE. 2016;11(5):e0155525. https:\/\/doi.org\/10.1371\/journal.pone.0155525.","journal-title":"PLoS ONE"},{"key":"7333_CR32","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.5588\/ijtld.15.0493","volume":"20","author":"M Adjobimey","year":"2016","unstructured":"Adjobimey M, Masserey E, Adjonou C. Implementation of isoniazid preventive therapy in children aged under 5 years exposed to tuberculosis in Benin. Int J Tuberc Lung Dis. 2016;20:1055\u20139.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"4","key":"7333_CR33","doi-asserted-by":"publisher","first-page":"226","DOI":"10.5588\/pha.16.0073%0A","volume":"6","author":"U Egere","year":"2016","unstructured":"Egere U, Sillah A, Togun T, Kandeh S, Cole F, Jallow A, et al. Isoniazid preventive treatment among child contacts of adults with smear-positive tuberculosis in The Gambia. Public Heal Action. 2016;6(4):226\u201331. https:\/\/doi.org\/10.5588\/pha.16.0073%0A.","journal-title":"Public Heal Action."},{"issue":"4","key":"7333_CR34","doi-asserted-by":"publisher","first-page":"479","DOI":"10.5588\/ijtld.15.0609","volume":"20","author":"APB Silva","year":"2016","unstructured":"Silva APB, Hill P, Belo MTCT, Rabelo SG, Menzies D, Trajman A. Non-completion of latent tuberculous infection treatment among children in Rio de Janeiro State, Brazil. Int J Tuberc Lung Dis. 2016;20(4):479\u201386.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"11","key":"7333_CR35","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/S1473-3099(16)30216-X","volume":"16","author":"H Alsdurf","year":"2016","unstructured":"Alsdurf H, Hill PC, Matteelli A, Getahun H, Menzies D. The cascade of care in diagnosis and treatment of latent tuberculosis infection: a systematic review and meta-analysis. Lancet Infect Dis. 2016;16(11):1269\u201378. https:\/\/doi.org\/10.1016\/S1473-3099(16)30216-X.","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"7333_CR36","doi-asserted-by":"publisher","first-page":"e0154843","DOI":"10.1371\/journal.pone.0154843","volume":"11","author":"AMC Mendonca","year":"2016","unstructured":"Mendonca AMC, Kritski AL, Land MGP, Sant\u2019Anna CC. Abandonment of treatment for latent tuberculosis infection and socioeconomic factors in children and adolescents: Rio De Janeiro, Brazil. PLoS ONE. 2016;11(5):e0154843.","journal-title":"PLoS ONE"},{"issue":"1","key":"7333_CR37","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1093\/tropej\/fmw086","volume":"1","author":"AR Singh","year":"2017","unstructured":"Singh AR, Kharate A, Bhat P, Kokane AM, Bali S, Sahu S, et al. Isoniazid preventive therapy among children living with tuberculosis patients: is it working? A mixed-method study from Bhopal, India. J Trop Pediatr. 2017;1(1):12. https:\/\/doi.org\/10.1093\/tropej\/fmw086.","journal-title":"J Trop Pediatr"},{"issue":"9","key":"7333_CR38","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.5588\/ijtld.16.0471","volume":"21","author":"DG Datiko","year":"2017","unstructured":"Datiko DG, Yassin MA, Theobald SJ, Cuevas LE. A community-based isoniazid preventive therapy for the prevention of childhood tuberculosis in Ethiopia. Int J Tuberc Lung Dis. 2017;21(9):1002\u20137.","journal-title":"Int J Tuberc Lung Dis"},{"key":"7333_CR39","doi-asserted-by":"crossref","unstructured":"Pothukuchi M, Nagaraja SB, Kelamane S, Satyanarayana S, Shashidhar, Babu S, et al. Tuberculosis contact screening and isoniazid preventive therapy in a South Indian district: operational issues for programmatic consideration. PLoS One. 2011;6(7):e22500.","DOI":"10.1371\/journal.pone.0022500"},{"issue":"2","key":"7333_CR40","doi-asserted-by":"publisher","first-page":"154","DOI":"10.5588\/ijtld.16.0624","volume":"21","author":"SS Chiang","year":"2017","unstructured":"Chiang SS, Roche S, Contreras C, Del Castillo H, Canales P, Jimenez J, et al. Barriers to the treatment of childhood tuberculous infection and tuberculosis disease: a qualitative study. Int J Tuberc Lung Dis. 2017;21(2):154\u201360. https:\/\/doi.org\/10.5588\/ijtld.16.0624.","journal-title":"Int J Tuberc Lung Dis"},{"key":"7333_CR41","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.5588\/ijtld.15.0952","volume":"20","author":"R Triasih","year":"2016","unstructured":"Triasih R, Padmawati RS, Duke T, Robertson C, Sawyer SM, Graham SM. A mixed-methods evaluation of adherence to preventive treatment among child tuberculosis contacts in Indonesia. Int J Tuberc Lung Dis. 2016;20:1078\u201383.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"12","key":"7333_CR42","doi-asserted-by":"publisher","first-page":"932","DOI":"10.2471\/BLT.13.118414","volume":"91","author":"ME Rutherford","year":"2013","unstructured":"Rutherford ME, Ruslami R, Anselmo M, Alisjahbana B, Yulianti N, Sampurno H, et al. Management of children exposed to Mycobacterium tuberculosis: a public health evaluation in West Java, Indonesia. Bull World Health Organ. 2013;91(12):932-941A.","journal-title":"Bull World Health Organ"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07333-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-022-07333-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07333-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T10:04:22Z","timestamp":1649671462000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-022-07333-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,11]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["7333"],"URL":"https:\/\/doi.org\/10.1186\/s12879-022-07333-2","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,11]]},"assertion":[{"value":"5 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Research Ethics Committee at the National School of Public Health at Universidad de Antioquia (Act 156 of 6th December of 2016) and by the National Bioethics Council at the Ministry of Public Health of the Dominican Republic (Session of 17th January of 2017 and ratified its first amendment on 20th June of 2017). All methods were performed in accordance with the relevant guidelines and regulations from Dominican Republic and Colombia. Informed consent was designed and applied in agreement with the Helsinki declaration, Nuremberg code, Law 100 from Colombia, and Law 42-01 from the Dominican Republic. The no-maleficence, benevolence and justice principles were considered. Informed consent was obtained from all subjects and\/or their legal guardian(s).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Does not apply.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Authors have no conflict of interest to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"359"}}